Compounds > cgp 35348
Page last updated: 2024-08-26

cgp 35348 and taurine

cgp 35348 has been researched along with taurine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holopainen, I; Rau, C; Wojcik, WJ1
Crunelli, V; Dobolyi, A; Emri, Z; Juhász, G; Kékesi, KA; Nyitrai, G1
Bartels, H; Froestl, W; Gibson, KM; Greven, R; Grompe, M; Gupta, M; Hogema, BM; Jakobs, C; Jansen, EE; Snead, OC1

Other Studies

3 other study(ies) available for cgp 35348 and taurine

ArticleYear
Proposed antagonists at GABAB receptors that inhibit adenylyl cyclase in cerebellar granule cell cultures of rat.
    European journal of pharmacology, 1992, Oct-01, Volume: 227, Issue:2

    Topics: Adenylyl Cyclase Inhibitors; Amino Acids; Amino Acids, Neutral; Animals; Baclofen; Cells, Cultured; Cerebellum; Dose-Response Relationship, Drug; GABA-A Receptor Antagonists; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Taurine

1992
In vivo blockade of thalamic GABA(B) receptors increases excitatory amino-acid levels.
    European journal of pharmacology, 1996, Dec-30, Volume: 318, Issue:2-3

    Topics: Animals; Aspartic Acid; Baclofen; GABA-B Receptor Antagonists; Glutamic Acid; Male; Microdialysis; Organophosphorus Compounds; Rats; Rats, Wistar; Receptors, GABA-B; Taurine; Thalamus

1996
Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:1

    Topics: Aldehyde Oxidoreductases; Animals; Benzocycloheptenes; Body Weight; gamma-Aminobutyric Acid; Genotype; Injections, Intraperitoneal; Longevity; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Phenotype; Sodium Oxybate; Succinate-Semialdehyde Dehydrogenase; Survival; Taste; Taurine; Vigabatrin

2002